Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
2021
https://researcherprofiles.org/profile/251351527
34953520
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group
